How many drugs are covered by each data source?

  • FDA Approval Packages: 1443, 857 that are considered ‘full’ (including pharmacology, medical and chemistry reviews, etc.) and are mostly 1992 – present. There are also approximately 700 considered ‘partial’, which tend to be drugs approved prior to 1992 and for which we do not have the full list of FDA reviews. For these packages, we will often have the various approved labels, approval letters, and company-FDA correspondence.
  • Mosby’s Drug Consult (Package Inserts; “labels”): Covers 1751 drugs (US Approved). Most of which overlap with our FDA Approval Package coverage. This also includes drugs discontinued post-1997 (79 drugs). Mosby’s has been discontinued and will no longer be updated. The type of content found in Mosby’s will be replaced by updating with DailyMed labels, started in Oct 2007.
  • Meyler’s Side Effects of Drugs: Covers US–approved drugs, in addition hundreds of drugs approved only outside the US are included.
  • AERS (our post-market data: Covers all US-approved drugs on the market. Drugs which have been discontinued or withdrawn are not deleted. AERS (Adverse Event Reporting System database) has been online since 1998, replacing the older SRS. So some older, withdrawn drugs will not be in the AERS database.

PharmaPendium. Make informed drug development decisions.

Interested? Contact us today to find out more about how PharmaPendium could benefit you.

Demo or Quote

Would you like to find out how Pharmapendium’s unique benefits support you and your colleagues? Contact us now